EUVIMEDEUVIMED entdecken
Crossref

Use of “Conôro” natural broth in the treatment of obesity and dyslipidemia in Wistar rats (Rattus norvegicus)

Désirée Oulaï Tagninon, Aboubacar Coulibaly, Sylvestre Konan Kongoza, Mathieu Nahounou Bleyere, Betty Meuwiah Faulet, Jean Tia Gonnety

International Journal of Biological and Chemical Sciences · 09.06.2026 · 20 (1) · 155-165

DOI: 10.4314/ijbcs.v20i1.13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological and Chemical Sciences, online erschienen am 09.06.2026. Verfasst von Désirée Oulaï Tagninon und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dyslipidaemia associated with obesity is a major risk factor for atherosclerosis and increases the risk of cardiovascular disease. Hence, this study therefore aims to evaluate the effects of the natural broth “Conôro” on dyslipidaemia and obesity induced in Rattus norvegicus. Forty-eight Wistar rats were divided into six groups of eight rats. Group 1 (normal control) and group 2 (positive control) received a standard diet (pellets) and a high-fat diet without any treatment, respectively. Group 3, in addition to the high-fat diet, was treated with statin at a dose of 10 mg/kg body weight (reference molecule). Groups 4, 5 and 6 received 40 mg/kg body weight (bw), 80 mg/kg (bw) and 160 mg/kg (bw) of ‘Conôro’ respectively, along with a high-fat diet. On day 45, blood samples were taken to determine Total Cholesterol (TC), Triglycerides (TG), High-Density Lipoproteins (HDL), Low-Density Lipoproteins (LDL) and mass variation. Changes in mass variation and lipid and carbohydrate parameters revealed the onset of the disease, resulting in a significant increase in the mass variation of diseased rats, reaching +72.57% at the start of the study compared to -25.82% at the end of the study. The high-fat diet led to a significant increase (p < 0.05) in plasma atherogenic index levels (78.94%), athrogenic coefficient levels (75.61%), coronary risk levels (140.49%) and a reduction in cardioprotective indices (-82.85%) in the experimental rats. Administration of Conôro at a dose of 160 mg/kg (body weight) improved mass variation, lipid and carbohydrate parameters in dyslipidaemic and obese rats.

Zitieren

APA

Tagninon, D. O., Coulibaly, A., Kongoza, S. K., Bleyere, M. N., Faulet, B. M., & Gonnety, J. T. (2026). Use of “Conôro” natural broth in the treatment of obesity and dyslipidemia in Wistar rats (Rattus norvegicus). International Journal of Biological and Chemical Sciences, 20(1), 155-165. https://doi.org/10.4314/ijbcs.v20i1.13

Vancouver

Tagninon DO, Coulibaly A, Kongoza SK, Bleyere MN, Faulet BM, Gonnety JT. Use of “Conôro” natural broth in the treatment of obesity and dyslipidemia in Wistar rats (Rattus norvegicus). International Journal of Biological and Chemical Sciences. 2026;20(1):155-165. doi:10.4314/ijbcs.v20i1.13

BibTeX
@article{Tagninon2026,
  author = {Tagninon, Désirée Oulaï and Coulibaly, Aboubacar and Kongoza, Sylvestre Konan and Bleyere, Mathieu Nahounou and Faulet, Betty Meuwiah and Gonnety, Jean Tia},
  title = {Use of “Conôro” natural broth in the treatment of obesity and dyslipidemia in Wistar rats (Rattus norvegicus)},
  journal = {International Journal of Biological and Chemical Sciences},
  year = {2026},
  volume = {20},
  number = {1},
  pages = {155--165},
  doi = {10.4314/ijbcs.v20i1.13}
}
Kostenlos starten →